The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACER THERAPEUTICS INC | COM | 00444P108 | 364 | 114,175 | SH | SOLE | 114,175 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,841 | 751,012 | SH | SOLE | 751,012 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 231 | 78,500 | SH | SOLE | 78,500 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 1,552 | 2,740,417 | SH | SOLE | 2,740,417 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 18,792 | 1,239,568 | SH | SOLE | 1,239,568 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 4,814 | 1,463,188 | SH | SOLE | 1,463,188 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM | 03835L108 | 2,008 | 3,413,421 | SH | SOLE | 3,413,421 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 10,929 | 2,595,855 | SH | SOLE | 2,595,855 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 543 | 109,743 | SH | SOLE | 109,743 | 0 | 0 | ||
| CORREVIO PHARMA CORP | COM | 22026V105 | 1,019 | 509,356 | SH | SOLE | 509,356 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 5,102 | 860,449 | SH | SOLE | 860,449 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 3,107 | 3,711,999 | SH | SOLE | 3,711,999 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 28 | 13,705 | SH | SOLE | 13,705 | 0 | 0 | ||
| DURECT CORPORATION | COM | 266605104 | 184 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 7,802 | 129,867 | SH | SOLE | 129,867 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 3,848 | 5,790,269 | SH | SOLE | 5,790,269 | 0 | 0 | ||
| INTERPACE DIAGNOSTICS GROUP | COM NEW | 46062X204 | 922 | 1,160,378 | SH | SOLE | 1,160,378 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,285 | 3,825,903 | SH | SOLE | 3,825,903 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 383 | 33,033 | SH | SOLE | 33,033 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 2,983 | 29,965 | SH | SOLE | 29,965 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 6,663 | 4,502,301 | SH | SOLE | 4,502,301 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 2,685 | 3,703,420 | SH | SOLE | 3,703,420 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 4,727 | 314,073 | SH | SOLE | 314,073 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 11,339 | 681,812 | SH | SOLE | 681,812 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 344 | 29,675 | SH | SOLE | 29,675 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 4,537 | 230,201 | SH | SOLE | 230,201 | 0 | 0 | ||